What Does KAMADA Do?

Total employees329
HeadquartersNess Ziona
Founded1990

Kamada Ltd. is a global, vertically integrated biopharmaceutical company with a portfolio of marketed, plasma-derived therapies, a robust late-stage PDUFA-post marketing pipeline and proprietary protein engineering and platform technology. The Company is focused on plasma-derived protein therapeutics for orphan indications and has a commercial presence in more than 30 countries. Kamada develops, produces, and markets these biopharmaceutical products, with a primary focus on specialty plasma-derived products for critical care, immunology, and hematology, leveraging its expertise in protein separation and purification to address unmet medical needs.

Where Is KAMADA's Headquarters?

HQ Function

The headquarters serves as the central hub for Kamada's global operations, encompassing corporate management, research and development (R&D), and the primary manufacturing facility for its plasma-derived biopharmaceutical products.

Notable Features:

Located in the Weizmann Science Park, a prestigious center for scientific research and high-tech industries in Israel. The facility includes state-of-the-art manufacturing suites compliant with international Current Good Manufacturing Practices (cGMP) standards.

Work Culture:

Kamada promotes a collaborative, scientifically-driven, and innovative work environment focused on excellence and improving patient outcomes. The culture values teamwork, ethical practices, and continuous professional development, characteristic of a biopharmaceutical company dedicated to R&D and specialized manufacturing.

HQ Significance:

The Ness Ziona headquarters is paramount to Kamada's operations, housing its main manufacturing facility, advanced R&D laboratories, and corporate offices. This integration allows for streamlined development, production, and strategic oversight of its global biopharmaceutical business.

Values Reflected in HQ: The headquarters embodies Kamada's core values of innovation, quality, and scientific rigor. This is evident in its advanced technological infrastructure, modern facilities, and strategic placement within a leading global science park.

Location:

Kamada maintains a significant global presence, supporting functions such as research and development, cGMP-compliant manufacturing (primarily in Israel), clinical trial operations, global regulatory affairs, and worldwide commercial activities. While its core R&D and manufacturing are centralized in Israel, Kamada markets its products in over 30 countries. This is achieved through a direct sales force and commercial operations in the U.S., and an extensive network of strategic partners and distributors across Europe, Latin America, Asia, and other international markets.

Street Address:

2 Sapir St., Science Park, P.O. Box 4081

City:

Ness Ziona

State/Province:

Central District

Country:

Israel

Where Else Does KAMADA Operate Around the World?

Park Ridge, New Jersey, USA

Address: 1 Maynard Drive, Suite 2102, Park Ridge, NJ 07656

To manage and expand Kamada's commercial footprint and product availability in the North American market, including engagement with healthcare providers, patient organizations, payers, and U.S. regulatory authorities.

Multiple locations in Texas, USA (e.g., Houston, Conroe, Lufkin)

Address: Various locations, e.g., Kamada Plasma, 9901 S Main St, Houston, TX 77025 (example of one center)

To ensure a consistent, high-quality supply of human plasma for Kamada's manufacturing processes, supporting the company's vertical integration strategy and bolstering its supply chain security for critical medicines.

Buying Intent Signals for KAMADA

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading KAMADA? Meet the Executive Team

As of April 2025, KAMADA' leadership includes:

Amir London - Chief Executive Officer
Chaime Weiss - Chief Financial Officer
Naveh Tov, PhD - VP, Chief Technology Officer
Jon P. Knight - VP, U.S. Commercial Operations
Einat Brill Almon, PhD - VP, Research & Development
Miri Ben-Noon - VP, Quality Assurance
Ronen Mileguir - VP, Operations
Michal Ayalon, PhD - VP, Global Regulatory Affairs

Who's Investing in KAMADA?

KAMADA has been backed by several prominent investors over the years, including:

FIMI Opportunity Funds
The Phoenix Holdings Ltd.
Menora Mivtachim Holdings Ltd.

What Leadership Changes Has KAMADA Seen Recently?

Hire1
Exits0

Kamada strengthened its executive leadership with the appointment of Dr. Michal Ayalon as Vice President, Global Regulatory Affairs in late 2023. No other major high-level executive hires or departures were prominently announced in the publicly available records over the last 12 months (Approx. May 2023 - May 2024).

New Appointments:

Michal Ayalon, Ph.D., Dr. Michal Ayalon joined Kamada as Vice President, Global Regulatory Affairs, tasked with overseeing the company's worldwide regulatory activities and engagement with health authorities.

What Technology (Tech Stack) Is Used byKAMADA?

Discover the tools KAMADA uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

KAMADA Email Formats and Examples

Kamada Ltd. likely employs standard corporate email address formats. Common patterns observed for companies of its nature and in its industry include using the employee's first initial followed by their last name, or the first name and last name separated by a period. All email addresses would use the '@kamada.com' domain.

[first_initial][last]@kamada.com (e.g., jdoe@kamada.com) or [first].[last]@kamada.com (e.g., jane.doe@kamada.com)

Format

alondon@kamada.com (example for Amir London, using first initial last name format)

Example

75%

Success rate

What's the Latest News About KAMADA?

GlobeNewswire via Yahoo FinanceMay 9, 2024

Kamada Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Progress

Kamada announced its financial results for the first quarter of 2024, reporting total revenues of $30.2 million. The company emphasized strong sales growth for KEDRAB® and ongoing advancements in its portfolio of immunoglobulin products....more

GlobeNewswire via Kamada Official WebsiteApril 2, 2024

Kamada Announces U.S. FDA Approval of CYTOGAM® New Liquid Formulation

Kamada received approval from the U.S. Food and Drug Administration (FDA) for a new, ready-to-use liquid formulation of CYTOGAM® (Cytomegalovirus Immune Globulin Intravenous [Human]). This formulation offers enhanced convenience for healthcare providers and is used for the prophylaxis of cytomegalovirus disease associated with transplantation....more

GlobeNewswire via Kamada Official WebsiteFebruary 29, 2024

Kamada Announces Publication of Positive Phase 2 Clinical Trial Results for its Anti-CD20 Monoclonal Antibody in Development for the Treatment of Chronic Graft-Versus-Host Disease (cGvHD)

Kamada announced that positive results from a Phase 2 clinical trial of its investigational anti-CD20 monoclonal antibody were published in the peer-reviewed journal 'Transplantation and Cellular Therapy'. The study demonstrated promising efficacy and safety data for the antibody in the treatment of chronic Graft-Versus-Host Disease (cGvHD)....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including KAMADA, are just a search away.